Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Neurology

Daily Life and Long-Term Monitoring for DMD

At a Glance

Long-term management of Duchenne Muscular Dystrophy (DMD) requires a consistent daily routine and regular medical monitoring. Key focuses include daily safe physical therapy to prevent contractures, managing steroid side effects, and annual monitoring of heart, lung, and bone health.

While the initial diagnosis of Duchenne Muscular Dystrophy (DMD) can feel like a crisis, the long-term management of the condition is a marathon of consistency and proactive monitoring. By following an evidence-based surveillance schedule and making small, sustainable changes to daily life, you can significantly influence your child’s health, strength, and comfort over time [1][2].

The Surveillance Schedule: Staying One Step Ahead

Because DMD affects multiple systems, “wellness” is defined by regular monitoring of the heart, lungs, and bones [3]. Catching changes early—long before symptoms appear—allows your team to start protective medications that extend function [4][5].

Area of Health Primary Tool Frequency Purpose
Heart Cardiac MRI (CMR) or Echo Every 12 months [6] Monitor for fibrosis (scarring) and pump function [7].
Lungs Pulmonary Function Test (PFT) Every 6–12 months [8] Measure breathing strength (FVC) and cough effectiveness [9].
Bones DXA Scan & Spine X-rays Every 12–24 months [10] Monitor for osteoporosis and tiny spinal fractures from steroids [11].
Growth Height/Weight/Puberty Checks Every 6 months [12] Manage the side effects of chronic corticosteroid use [13].

Daily Life: Protection and Flexibility

In DMD, muscle cells are fragile. The goal of daily activity is to keep the body moving without causing accidental damage.

1. The Physical Therapy Routine

Consistency is key to preventing contractures (permanent tightening of the joints).

  • Daily Stretching: Focus on the “heel cords” (Achilles tendons), hamstrings, and hips [14]. Your physical therapist will teach you specific holds to maintain range of motion [15].
  • Avoiding “Eccentric” Contractions: These are movements where the muscle is lengthening while trying to work, such as walking down stairs or jumping off a step [16]. These movements are high-stress and can cause more muscle fiber damage [3].
  • Safe Exercise: Swimming and mild-to-moderate isometric exercises (like pushing against a stationary object) are generally safer and more sustainable [16].

2. Managing Steroid Side Effects

Corticosteroids are vital for strength, but they require a proactive management plan [17].

  • Nutrition: Steroids increase appetite. Working with a specialized dietitian can help you focus on high-protein, low-calorie foods to avoid excessive weight gain [12][18].
  • Bone Health: Along with calcium and Vitamin D, some children may need medications called bisphosphonates to keep their bones strong and prevent fractures [19][20].
  • Adrenal Awareness: Because the body stops making its own natural “stress hormone” while on steroids, you must never stop them suddenly. If your child is sick or needs surgery, they may need an extra “stress dose” to stay safe [21].

The Psychological Toll

DMD is a family diagnosis. The mental health of parents and siblings is just as important as the physical health of the child [22].

  • For the Child: As they grow, children may experience anxiety or frustration regarding their physical differences. Early connection to a counselor who specializes in chronic illness can provide them with tools to navigate these feelings [23].
  • For the Family: The “caregiver burden” is real. Joining a support group or working with a social worker at your neuromuscular clinic can help you process the transitions and maintain your own resilience [24].

Living with DMD means building a “new normal.” By committing to regular monitoring and a gentle daily routine, you are providing your child with the best possible foundation for a full and meaningful life into adulthood [2][25].

Return to the Home Page.

Common questions in this guide

How often does a child with DMD need heart and lung testing?
Children with DMD should have a cardiac MRI or echocardiogram every 12 months to monitor heart health. Lung function should be checked with a pulmonary function test every 6 to 12 months to measure breathing strength and cough effectiveness.
What type of physical therapy is safe for Duchenne muscular dystrophy?
Safe physical therapy for DMD focuses on daily stretching of the heel cords, hamstrings, and hips to prevent joint tightness. Swimming and mild isometric exercises are generally safe, but high-stress movements like jumping or walking down stairs should be avoided to prevent muscle damage.
How can we manage weight gain from steroids in DMD?
Corticosteroids can significantly increase appetite. Working with a specialized dietitian to create a meal plan focused on high-protein, low-calorie foods can help prevent excessive weight gain while maintaining proper nutrition.
What is a stress dose for steroids in DMD and why is it needed?
Because chronic steroid use stops the body from making its own natural stress hormones, patients cannot safely stop taking them abruptly. If a child becomes sick or requires surgery, a doctor may prescribe an extra stress dose to help their body handle the physical stress safely.
When should we schedule DXA scans for a child on DMD steroids?
A DXA scan and spine X-rays should typically be performed every 12 to 24 months. These scans monitor for osteoporosis and tiny spinal fractures, which are common side effects of long-term corticosteroid use.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How do we adjust my child's physical therapy routine to ensure we are maintaining flexibility without causing over-exertion or muscle damage?
  2. 2.At what point should we schedule the first DXA scan and spinal X-ray to monitor for bone thinning from the steroids?
  3. 3.Can you refer us to a specialized dietitian who can help us manage weight and nutrition during steroid treatment?
  4. 4.How will you monitor for adrenal suppression, and what is our plan if my child becomes ill or needs surgery?
  5. 5.What mental health resources (like a social worker or psychologist) do you recommend for families navigating the long-term reality of DMD?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (25)
  1. 1

    Evaluating Implementation of the Updated Care Considerations for Duchenne Muscular Dystrophy.

    Ong KS, Kinnett K, Soelaeman R, et al.

    Pediatrics 2018; (142(Suppl 2)):S118-S128 doi:10.1542/peds.2018-0333N.

    PMID: 30275256
  2. 2

    Adult North Star Network (ANSN): Consensus Guideline For The Standard Of Care Of Adults With Duchenne Muscular Dystrophy.

    Quinlivan R, Messer B, Murphy P, et al.

    Journal of neuromuscular diseases 2021; (8(6)):899-926 doi:10.3233/JND-200609.

    PMID: 34511509
  3. 3

    Duchenne muscular dystrophy.

    Duan D, Goemans N, Takeda S, et al.

    Nature reviews. Disease primers 2021; (7(1)):13 doi:10.1038/s41572-021-00248-3.

    PMID: 33602943
  4. 4

    X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy.

    Nakamura A

    Pharmaceuticals (Basel, Switzerland) 2015; (8(2)):303-20 doi:10.3390/ph8020303.

    PMID: 26066469
  5. 5

    Case Report: Home initiation of nocturnal non-invasive ventilation in two adolescents with Duchenne muscular dystrophy and comorbid autism spectrum disorder and ADHD.

    Weerkamp PMM, Voermans M, Finders M, et al.

    Frontiers in pediatrics 2025; (13()):1525365 doi:10.3389/fped.2025.1525365.

    PMID: 40161498
  6. 6

    Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee.

    Esteso P, Auerbach SR, Bansal N, et al.

    Cardiology in the young 2025; (35(4)):770-775 doi:10.1017/S1047951125000587.

    PMID: 40012319
  7. 7

    Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy.

    Ganigara M, Sharma B, Komalla RB, et al.

    Annals of pediatric cardiology 2016; (9(2)):190-1 doi:10.4103/0974-2069.181496.

    PMID: 27212861
  8. 8

    Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging.

    Batra A, Barnard AM, Lott DJ, et al.

    BMC cardiovascular disorders 2022; (22(1)):260 doi:10.1186/s12872-022-02688-5.

    PMID: 35681116
  9. 9

    Association between pulmonary function and left ventricular volume and function in duchenne muscular dystrophy.

    Khokhar A, Nair A, Midya V, et al.

    Muscle & nerve 2019; (60(3)):286-291 doi:10.1002/mus.26623.

    PMID: 31250930
  10. 10

    Fractures and bone health monitoring in boys with Duchenne muscular dystrophy managed within the Scottish Muscle Network.

    Joseph S, Wang C, Di Marco M, et al.

    Neuromuscular disorders : NMD 2019; (29(1)):59-66 doi:10.1016/j.nmd.2018.09.005.

    PMID: 30473133
  11. 11

    The burden of bone disease in Duchenne muscular dystrophy: age-specific prevalence of osteoporosis and low bone density.

    Nasomyont N, Tian C, Hornung L, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2026; doi:10.1007/s00198-026-07963-1.

    PMID: 41912872
  12. 12

    Nutritional and Gastrointestinal Management of the Patient With Duchenne Muscular Dystrophy.

    Brumbaugh D, Watne L, Gottrand F, et al.

    Pediatrics 2018; (142(Suppl 2)):S53-S61 doi:10.1542/peds.2018-0333G.

    PMID: 30275249
  13. 13

    Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.

    Guglieri M, Bushby K, McDermott MP, et al.

    Contemporary clinical trials 2017; (58()):34-39 doi:10.1016/j.cct.2017.04.008.

    PMID: 28450193
  14. 14

    Progression of Ankle Plantarflexion Contractures and Functional Decline in Duchenne Muscular Dystrophy: Implications for Physical Therapy Management.

    Kiefer M, Bonarrigo K, Quatman-Yates C, et al.

    Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association 2019; (31(1)):61-66 doi:10.1097/PEP.0000000000000553.

    PMID: 30557283
  15. 15

    Virtual Reality Computer Gaming with Dynamic Arm Support in Boys with Duchenne Muscular Dystrophy.

    Heutinck L, Jansen M, van den Elzen Y, et al.

    Journal of neuromuscular diseases 2018; (5(3)):359-372 doi:10.3233/JND-180307.

    PMID: 29991140
  16. 16

    Safety, feasibility, and efficacy of strengthening exercise in Duchenne muscular dystrophy.

    Lott DJ, Taivassalo T, Cooke KD, et al.

    Muscle & nerve 2021; (63(3)):320-326 doi:10.1002/mus.27137.

    PMID: 33295018
  17. 17

    Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy.

    Biggar WD, Skalsky A, McDonald CM

    Journal of neuromuscular diseases 2022; (9(4)):463-476 doi:10.3233/JND-210776.

    PMID: 35723111
  18. 18

    Pilot study of a virtual weight management program for Duchenne muscular dystrophy.

    Billich N, Bray P, Truby H, et al.

    Muscle & nerve 2024; (69(4)):459-466 doi:10.1002/mus.28065.

    PMID: 38353295
  19. 19

    Optimizing Bone Health in Duchenne Muscular Dystrophy.

    Buckner JL, Bowden SA, Mahan JD

    International journal of endocrinology 2015; (2015()):928385 doi:10.1155/2015/928385.

    PMID: 26124831
  20. 20

    Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study.

    Moretti A, Liguori S, Paoletta M, et al.

    Advances in therapy 2022; (39(7)):3308-3315 doi:10.1007/s12325-022-02179-1.

    PMID: 35614293
  21. 21

    Adrenal Suppression From Vamorolone and Prednisone in Duchenne Muscular Dystrophy: Results From the Phase 2b Clinical Trial.

    Ahmet A, Tobin R, Dang UJ, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(2)):334-344 doi:10.1210/clinem/dgae521.

    PMID: 39097643
  22. 22

    Quality of Life and Financial Burden in Duchenne Muscular Dystrophy in Greece: Insights into Health System Performance in the Post-Pandemic Context.

    Katsomiti E, Kastanioti C, Chroni E, et al.

    Healthcare (Basel, Switzerland) 2025; (13(22)) doi:10.3390/healthcare13222835.

    PMID: 41302223
  23. 23

    Neurological impairments in Duchenne muscular dystrophy: A comprehensive review.

    Zhang XF, Hu W, Hu J

    Acta neurologica Belgica 2025; doi:10.1007/s13760-025-02880-2.

    PMID: 40903659
  24. 24

    Study of Duchenne muscular dystrophy long-term survivors aged 40 years and older living in specialized institutions in Japan.

    Saito T, Kawai M, Kimura E, et al.

    Neuromuscular disorders : NMD 2017; (27(2)):107-114 doi:10.1016/j.nmd.2016.11.012.

    PMID: 28003112
  25. 25

    Duchenne muscular dystrophy: the management of scoliosis.

    Archer JE, Gardner AC, Roper HP, et al.

    Journal of spine surgery (Hong Kong) 2016; (2(3)):185-194 doi:10.21037/jss.2016.08.05.

    PMID: 27757431

This guide on DMD daily management is for informational purposes only. Always consult your child's neuromuscular team before altering their physical therapy, diet, or steroid regimen.

Get notified when new evidence is published on Duchenne muscular dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.